All attending UK organisations

UK companies attending Biotech Showcase 2020 as part of the official delegation

(Click here to search profiles): BioPartner UK/Dept Int Trade, Black Belt TX, Chronos Therapeutics, Closed Loop Medicine, Isogenica, Medisieve, Microbiotica, OxStem, Pathfinder Medical, Pebmond Associates, Pneumagen.

Other UK companies associated with the delegation*:
Abzena, Albumedix, Barrington James, CIMYM BioSciences, Karus Therapeutics, MGB Biopharma, Orbit Discovery, Sareum, Sygnature Discovery, SYNthesis Research, Valo Therapeutics.

UK Presenting companies:
https://informaconnect.com/biotech-showcase/presentation-information/

All attending UK companies:
4BIO Capital, Abzena, Albion Capital, Albumedix, ALS:Rx, ANGLE, Apex Healthcare Consulting, Arrowfield Capital, AstraZeneca, Atelix, Avacta Life Sciences, Barrington James, BioPartner UK, Black Belt TX, Blackford Analysis, Blackhawk Innovation, Bold Health, Bridge Valley Ventures, CALCIVIS, Cambridge Innovation Capital, Capella BioScience, Capital International Investors, Cell and Gene Therapy Catapult, Censo Biotechnolologies, CEPI, Chronos Therapeutics, CIMYM BioSciences, Citigate Dewe Rogerson, Clinical Accelerator, Closed Loop Medicine, CN Bio Innovations, Coulter Partners, CytoSorbents Corporation, Delin Ventures, Dynamic Metrics, Edinburgh Molecular Imaging, Edison, Elasmogen, Eleusis, Endomagnetics, Engitix Therapeutics, Epidarex Capital, ERA Consulting UK, ESM Biotech, Esperante, GHO Capital Partners, GTJA Investment Group, Healx, IAG, IGEM Therapeutics, Illingworth Research Group, Immupharma, InHealth Ventures, Intract Pharma, Isogenica, KaNDy Therapeutics, Karus Therapeutics, LifeArc, LIfT BioSciences, Locate Bio, Macrophage Pharma, Medisieve, MGB Biopharma, Microbiotica, MIP Diagnostics, MMC Ventures, Momentum Biotech, Morgan Prestwich, Nanomerics, Neem Biotech, Nerre Therapeutics, NIHR, o2h Ventures, Oppilotech, Optum Ventures, Orbit Discovery, Oxford BioMedica, Oxsonics Therapeutics, Oxstem, Pathfinder Medical, Pneumagen, Prokarium, Quotient Sciences, Random42 Scientific Communication, Rexgenero, Rosetta Capital, RT Partners, RYSE Asset Management, Sachs Associates, Sanger Institute, Sareum, Scius Communications, Sense Biodetection, Silence Therapeutics, Silicon Valley Bank, Somanauitx, SomaServe, Southern Star Research, Sygnature Discovery, Syneos Health, SYNthesis Research, Talentmark, Tarian Biotechnology, Teijin Pharma, The Institute of Cancer Research, Torreya, UCB Ventures, Valo Therapeutics, Virokine Therapeutics, Worldwide Clinical Trials.

Join them here!